Market Cap 110.84M
Revenue (ttm) 0.00
Net Income (ttm) -15.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 46,600
Avg Vol 74,724
Day's Range N/A - N/A
Shares Out 13.86M
Stochastic %K 87%
Beta 1.61
Analysts Strong Sell
Price Target $42.00

Company Profile

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in...

Industry: Biotechnology
Sector: Healthcare
Phone: 832 819 3232
Address:
Building 14, 3992 Bluebonnet Dr., Stafford, United States
doc123266
doc123266 Dec. 5 at 12:12 AM
$GLSI another day green with AH hold. If all this talk about pulling in your shares from lending is accurate this whole short theory is really exposing itself.
0 · Reply
Cliffhangers
Cliffhangers Dec. 4 at 10:22 PM
$GLSI echo on @OsmanGazi's point. The shorts been limiting @GLSI's atm financing capability just to line their own pockets with cheap shares. They see the potential and try hard to steal shares by all means, especially when news is getting close. I feel good holding my shares strong in support of p3 journey, which is running in full gears. Holding shares of those pump n dump biotechs is just like gambling. Being a share holder of @GLSI makes me feel good cz I know I'm helping those who are suffering from the disease.
0 · Reply
skiddy5
skiddy5 Dec. 4 at 9:33 PM
$GLSI the desperation covering everytime this hits low 8s. Lol
0 · Reply
Lets_Go_Brndn
Lets_Go_Brndn Dec. 4 at 9:03 PM
$GLSI Should have 100k back into cash tomorrow or Monday (not me). Will Make it more difficult for shorts. PR would be so nice
2 · Reply
msgbrdinfo
msgbrdinfo Dec. 4 at 9:01 PM
$GLSI The shorts having trouble keeping the price down now that retail has had enuf of their shit? Maybe....just maybe.
0 · Reply
Toontje1
Toontje1 Dec. 4 at 7:19 PM
$GLSI ❤️ ❤️ ❤️
0 · Reply
OsmanGazi
OsmanGazi Dec. 4 at 7:01 PM
$GLSI We are living in a sad time when greed seems more important than saving lives. Short sellers try to destroy this company by pushing it down, hoping it goes bankrupt. Imagine your wife or mother battling breast cancer , and instead of caring about the cure, you are rooting against the very company trying to save them. You are short on GLSI, and you would rather see GLSI fail than see your own family helped. It’s unbelievable. It’s disgusting, honestly. Sometimes I feel like we humans have become so blinded by money that we have lost our basic sense of humanity. No animal would behave like this. Sometimes it just feels like we, as a species, are failing. I know there are many amazing people on earth But then we have just disgusting humans don’t care about others. Sorry, that’s just how I feel sometimes.
2 · Reply
TrailBoss
TrailBoss Dec. 4 at 6:40 PM
$GLSI I hope the shorts get burned good on this one. They have been trying to drive down the stock price with every single positive bit of good news that has come out about GLSI. I can't really can't think of many negatives about Greenwich, but I can talk for hours about the positives. For instance, I could talk about how my sister after surviving breast cancer went through the 2nd clinical trial and because she did, it more then likely saved her life. I could talk about how she got to continue being a mom to 3 young kids and how my mother didn't loose a daughter. I firmly believe in glsi, and that GLSI-100 will be approved and successful. I also believe that shorting & stock lending this stock not only screws over retail investors, but also the people that support GlSI on one level or another. HOLD THE LINE LONGS! I hope when this gets approved it saves countless lives and makes all that held bunch of money.
1 · Reply
GLSIforthewin
GLSIforthewin Dec. 4 at 6:24 PM
0 · Reply
Akcash
Akcash Dec. 4 at 1:01 PM
$GLSI so ive gone even deeper…. this is an upgraded version of phase 3 failure E75 neuvax…. could get our DFS benefit here because of some major mechanism differences. GLTA manage your position size accordingly
1 · Reply
Latest News on GLSI
Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 3, 2025, 8:00 AM EDT - 8 months ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01


Greenwich LifeSciences Provides Update on Commercial Manufacturing

Jan 22, 2025, 6:00 AM EST - 11 months ago

Greenwich LifeSciences Provides Update on Commercial Manufacturing


Greenwich LifeSciences Partners with GIM in Italy

Nov 26, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Partners with GIM in Italy


Greenwich LifeSciences Provides Update on Corporate Events

Nov 18, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Corporate Events


Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 26, 2024, 7:33 AM EDT - 1 year ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again


Greenwich LifeSciences Provides Year End Update

Dec 29, 2022, 6:48 AM EST - 3 years ago

Greenwich LifeSciences Provides Year End Update


Greenwich LifeSciences: Persevering CEO And Interesting Data

Sep 6, 2022, 5:40 PM EDT - 3 years ago

Greenwich LifeSciences: Persevering CEO And Interesting Data


Here's Why Greenwich Lifesciences Shares Are Popping Off Today

Jul 12, 2022, 1:18 PM EDT - 3 years ago

Here's Why Greenwich Lifesciences Shares Are Popping Off Today


Greenwich LifeSciences to Resume Stock Repurchase Program

May 23, 2022, 7:00 AM EDT - 3 years ago

Greenwich LifeSciences to Resume Stock Repurchase Program


Greenwich LifeSciences: A First Look

May 19, 2022, 11:12 AM EDT - 3 years ago

Greenwich LifeSciences: A First Look


doc123266
doc123266 Dec. 5 at 12:12 AM
$GLSI another day green with AH hold. If all this talk about pulling in your shares from lending is accurate this whole short theory is really exposing itself.
0 · Reply
Cliffhangers
Cliffhangers Dec. 4 at 10:22 PM
$GLSI echo on @OsmanGazi's point. The shorts been limiting @GLSI's atm financing capability just to line their own pockets with cheap shares. They see the potential and try hard to steal shares by all means, especially when news is getting close. I feel good holding my shares strong in support of p3 journey, which is running in full gears. Holding shares of those pump n dump biotechs is just like gambling. Being a share holder of @GLSI makes me feel good cz I know I'm helping those who are suffering from the disease.
0 · Reply
skiddy5
skiddy5 Dec. 4 at 9:33 PM
$GLSI the desperation covering everytime this hits low 8s. Lol
0 · Reply
Lets_Go_Brndn
Lets_Go_Brndn Dec. 4 at 9:03 PM
$GLSI Should have 100k back into cash tomorrow or Monday (not me). Will Make it more difficult for shorts. PR would be so nice
2 · Reply
msgbrdinfo
msgbrdinfo Dec. 4 at 9:01 PM
$GLSI The shorts having trouble keeping the price down now that retail has had enuf of their shit? Maybe....just maybe.
0 · Reply
Toontje1
Toontje1 Dec. 4 at 7:19 PM
$GLSI ❤️ ❤️ ❤️
0 · Reply
OsmanGazi
OsmanGazi Dec. 4 at 7:01 PM
$GLSI We are living in a sad time when greed seems more important than saving lives. Short sellers try to destroy this company by pushing it down, hoping it goes bankrupt. Imagine your wife or mother battling breast cancer , and instead of caring about the cure, you are rooting against the very company trying to save them. You are short on GLSI, and you would rather see GLSI fail than see your own family helped. It’s unbelievable. It’s disgusting, honestly. Sometimes I feel like we humans have become so blinded by money that we have lost our basic sense of humanity. No animal would behave like this. Sometimes it just feels like we, as a species, are failing. I know there are many amazing people on earth But then we have just disgusting humans don’t care about others. Sorry, that’s just how I feel sometimes.
2 · Reply
TrailBoss
TrailBoss Dec. 4 at 6:40 PM
$GLSI I hope the shorts get burned good on this one. They have been trying to drive down the stock price with every single positive bit of good news that has come out about GLSI. I can't really can't think of many negatives about Greenwich, but I can talk for hours about the positives. For instance, I could talk about how my sister after surviving breast cancer went through the 2nd clinical trial and because she did, it more then likely saved her life. I could talk about how she got to continue being a mom to 3 young kids and how my mother didn't loose a daughter. I firmly believe in glsi, and that GLSI-100 will be approved and successful. I also believe that shorting & stock lending this stock not only screws over retail investors, but also the people that support GlSI on one level or another. HOLD THE LINE LONGS! I hope when this gets approved it saves countless lives and makes all that held bunch of money.
1 · Reply
GLSIforthewin
GLSIforthewin Dec. 4 at 6:24 PM
0 · Reply
Akcash
Akcash Dec. 4 at 1:01 PM
$GLSI so ive gone even deeper…. this is an upgraded version of phase 3 failure E75 neuvax…. could get our DFS benefit here because of some major mechanism differences. GLTA manage your position size accordingly
1 · Reply
Alwaysdiversify
Alwaysdiversify Dec. 4 at 12:43 PM
$GLSI Zero shares available to borrow. Fee now up to 33.6%. Ummmmmm...... https://chartexchange.com/symbol/nasdaq-glsi/borrow-fee/
2 · Reply
Rolltide2020
Rolltide2020 Dec. 4 at 12:04 PM
$GLSI Becoming expensive for shorty.
0 · Reply
Cliffhangers
Cliffhangers Dec. 4 at 3:17 AM
$GLSI Hit a major milestone today. Enrollment targets (1000 in P3 and 250 in open label) will soon be reached with 150 patients screening rate per quarter. Treatment's been ongoing since 2023 and IA can often be based on a subset of full enrollment, say half or two thirds of the total enrolled. I won't second guess the time and I'm confortable holding at this price. Will buy more. Up potential is enticing.
1 · Reply
doc123266
doc123266 Dec. 4 at 1:06 AM
$GLSI I actually really like no AH trading. That’s where all the manipulation seemed to be happening. Steady gain. Hold steady
0 · Reply
Akcash
Akcash Dec. 4 at 12:21 AM
$GLSI So mittendorf took a run with a failed phase three for AE37 peptide vaccine. Here are the differences AE37 — an Ii-Key/HER2 hybrid MHC-class-II peptide (derived from HER2 aa776–790) given with GM-CSF to stimulate helper (CD4⁺) T-cells. GLSI-100 (GP2 + GM-CSF) — a vaccine whose active peptide GP2 is a 9-amino-acid HER2 MHC-class-I epitope (aa654–662) given with GM-CSF to stimulate cytotoxic (CD8⁺) T-cells AE37 = HER2 MHC-II helper peptide vaccine (CD4 focus), earlier-phase evidence, broader HLA applicability. GLSI-100 (GP2 + GM-CSF) = HER2 MHC-I (GP2) vaccine (CD8 focus), more HLA-restricted (HLA-A*02), advanced into a large Phase III FLAMINGO-01 program with regulatory attention
1 · Reply
Akcash
Akcash Dec. 4 at 12:16 AM
$GLSI Here is some deep DD for you bulls... https://academic.oup.com/jnci/article-abstract/107/2/djv022/906103?redirectedFrom=fulltext Elizabeth Mittendorf is at GLSI now with Snehal... anyone wanna run with this lead and tell us more?
2 · Reply
geronimlopez
geronimlopez Dec. 4 at 12:04 AM
$GLSI Across the 700+ biotech names on NASDAQ, very few ever check the real high-conviction boxes: Meaningful clinical efficacy: <2% High insider ownership: <1% Clear MoA + compelling safety: <1% Fast Track or better: <0.5% Strong OS/DFS survival signals: <0.3% Microcap and legitimately high-quality: <0.5% True institutional conviction at microcap levels: <0.1% When you stack ALL of these criteria at the same time, the list basically becomes microscopic. GLSI is one of the extremely rare biotechs that qualifies on every single metric.
0 · Reply
doc123266
doc123266 Dec. 3 at 10:06 PM
$GLSI I like that green close.
1 · Reply
GLSIforthewin
GLSIforthewin Dec. 3 at 4:51 PM
$GLSI Would you look at that? Ask a question on stocktwits and Snehal answers! Based on 1.25 people being screened per site each quarter and 40 sites in the US in 2023 and 87% enrollment rate of those screened, they had 150 enrolled by the end of 2023. Even better, they have at least 870 enrolled currently! I still think IA is a ways out, but more importantly it looks like GLSI-100 is working well! In the meantime, Snehal is trying to pump the price up with not so cryptic data at every turn.
5 · Reply
Katkimkimkim
Katkimkimkim Dec. 3 at 4:34 PM
$GLSI is it possible that the company knows how many were screened but doesnt know how many were enrolled?
1 · Reply
msgbrdinfo
msgbrdinfo Dec. 3 at 4:08 PM
$GLSI Well, todays news release should quiet the posters worried about sign ups. Regarding comparing to other cancer trials, we have to keep in mind that practically all.of them have toxic side effects. Not so easy to sign up participants. GLSI-100 has practically no toxic side effects so not so hard to enlist. They actually have volunteers asking to join.
0 · Reply
prismmarketview
prismmarketview Dec. 3 at 3:52 PM
Greenwich LifeSciences (Nasdaq: $GLSI) screens 1,000+ patients in FLAMINGO-01 Phase III trial of GLSI-100 for HER2+ breast cancer, advancing global enrollment and interim analyses. https://prismmarketview.com/greenwich-lifesciences-screens-over-1000-patients-in-flamingo-01-phase-iii-breast-cancer-trial/
0 · Reply